Syra Health Corp. (SYRA)
NASDAQ: SYRA · IEX Real-Time Price · USD
1.370
+0.170 (14.17%)
May 3, 2024, 3:04 PM EDT - Market open

Syra Health Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current202320222021
Market Capitalization
914--
Enterprise Value
61110
PE Ratio
-4.81-4.81--
PS Ratio
1.632.56--
PB Ratio
2.243.52--
P/FCF Ratio
-5.10-5.10--
P/OCF Ratio
-5.12-5.12--
EV/Sales Ratio
1.082.010.170.17
EV/EBITDA Ratio
-3.92-3.92-0.4710.04
EV/EBIT Ratio
-3.85-3.85-0.45-74.04
EV/FCF Ratio
-4.00-4.00-0.39-2.57
Debt / Equity Ratio
0.060.061.32-47.97
Debt / EBITDA Ratio
-0.09-0.09-0.4714.18
Debt / FCF Ratio
-0.09-0.09-0.40-3.63
Quick Ratio
4.834.830.780.80
Current Ratio
5.255.250.920.85
Asset Turnover
1.901.903.93-
Interest Coverage
-53.73-53.73-73.24-
Return on Equity (ROE)
-641.00%-641.00%-602.60%-
Return on Assets (ROA)
-101.10%-101.10%-148.30%-
Return on Capital (ROIC)
-67.76%-67.76%-127.04%-0.98%
Earnings Yield
-32.74%-20.78%--
FCF Yield
-30.91%-19.62%--
Buyback Yield / Dilution
-60.40%-60.40%-264.93%-
Total Shareholder Return
-60.40%-60.40%-264.93%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).